{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:07:06Z","timestamp":1791230826052,"version":"4.1.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1097\/01.inf.0000160916.47479.22","type":"journal-article","created":{"date-parts":[[2005,5,5]],"date-time":"2005-05-05T04:01:03Z","timestamp":1115265663000},"page":"S66-S68","source":"Crossref","is-referenced-by-count":39,"title":["Use of Antibiotics in the Prevention and Treatment of Pertussis"],"prefix":"10.1097","volume":"24","author":[{"given":"Carl-Heinz Wirsing","family":"von K\u00f6nig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20210202","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1517\/14656566.2.8.1275","article-title":"Current pharmacotherapy of pertussis.","volume":"2","author":"Kerr","year":"2001","journal-title":"Expert Opin Pharmacother"},{"key":"R2-13-20210202","first-page":"205","article-title":"Essential Procedures for Clinical Microbiology.","author":"Hindler","year":"1998"},{"key":"R3-13-20210202","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/BF02962373","article-title":"State of art in antibacterial susceptibility of Bordetella pertussis and antibiotic treatment of pertussis.","volume":"26","author":"Hoppe","year":"1998","journal-title":"Infection"},{"key":"R4-13-20210202","first-page":"807","article-title":"Erythromycin-resistant Bordetella pertussis, Yuma County, Arizona, May-October 1994.","volume":"43","author":"Lewis","year":"1994","journal-title":"MMWR"},{"key":"R5-13-20210202","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1128\/JCM.35.11.2989-2991.1997","article-title":"Surveillance and detection of erythromycin resistance in Bordetella pertussis isolates recovered from a pediatric population in the intermountain west region of the United States.","volume":"35","author":"Korgenski","year":"1997","journal-title":"J Clin Microbiol"},{"key":"R6-13-20210202","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1128\/JCM.40.8.2942-2944.2002","article-title":"Bordetella pertussis isolates with a heterogeneous phenotype for erythromycin resistance.","volume":"40","author":"Wilson","year":"2002","journal-title":"J Clin Microbiol"},{"key":"R7-13-20210202","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1128\/JCM.41.3.1167-1172.2003","article-title":"Identification of a mutation associated with erythromycin resistance in Bordetella pertussis: implications for surveillance of antimicrobial resistance.","volume":"41","author":"Bartkus","year":"2003","journal-title":"J Clin Microbiol"},{"key":"R8-13-20210202","first-page":"1057","article-title":"Reoccurrence of culture-positive pertussis in an infant initially treated with azithromycin and steroids.","volume":"156","author":"Steinberg","year":"2002","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R9-13-20210202","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/00006454-199203000-00003","article-title":"Comparison of erythromycin estolate and erythromycin ethylsuccinate for treatment of pertussis.","volume":"11","author":"Hoppe","year":"1992","journal-title":"Pediatr Infect Dis J"},{"key":"R11-13-20210202","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1542\/peds.100.1.65","article-title":"Seven days of erythromycin estolate is as effective as fourteen days for the treatment of Bordetella pertussis infections.","volume":"100","author":"Halperin","year":"1997","journal-title":"Pediatrics"},{"key":"R12-13-20210202","first-page":"471","article-title":"Hypertrophic pyloric stenosis in infants following pertussis prophylaxis with erythromycin.","volume":"26;283","year":"2000","journal-title":"JAMA"},{"key":"R13-13-20210202","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/S0140-6736(99)10073-4","article-title":"Infantile hypertrophic pyloric stenosis after pertussis prophylaxis with erythromycin: a case review and cohort study.","volume":"354","author":"Honein","year":"1999","journal-title":"Lancet"},{"key":"R14-13-20210202","doi-asserted-by":"crossref","first-page":"929","DOI":"10.2165\/00002018-200225130-00004","article-title":"Association of erythromycin and infantile hypertrophic pyloric stenosis: causal or coincidental?","volume":"25","author":"Hauben","year":"2002","journal-title":"Drug Saf"},{"key":"R15-13-20210202","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0022-3476(96)70163-4","article-title":"Efficacy of short-term treatment of pertussis with clarithromycin and azithromycin.","volume":"129","author":"Aoyama","year":"1996","journal-title":"J Pediatr"},{"key":"R17-13-20210202","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1097\/01.inf.0000083884.75901.1e","article-title":"Azithromycin for the treatment of pertussis.","volume":"22","author":"Pichichero","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"R18-13-20210202","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/00006454-200112000-00011","article-title":"Efficacy and safety of clarithromycin versus erythromycin for the treatment of pertussis: a prospective, randomized, single blind trial.","volume":"20","author":"Lebel","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"R19-13-20210202","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.inf.0000050666.26000.34","article-title":"Need for equivalence testing of efficacy of alternative antibiotics for treatment of pertussis.","volume":"22","author":"Baughman","year":"2003","journal-title":"Pediatr Infect Dis J"},{"issue":"suppl","key":"R20-13-20210202","first-page":"S1115","article-title":"Pediatric clinical trials and the use of ciprofloxazin in pediatrics.","volume":"22","author":"Lieberman","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"R21-13-20210202","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/00006454-198705000-00009","article-title":"Erythromycin in the treatment of pertussis: a study of bacteriologic and clinical effects.","volume":"6","author":"Bergquist","year":"1987","journal-title":"Pediatr Infect Dis J"},{"key":"R22-13-20210202","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s004310050836","article-title":"Factors influencing the spread of pertussis in households.","volume":"157","author":"Wirsing von K\u00f6nig","year":"1998","journal-title":"Eur J Pediatr"},{"key":"R23-13-20210202","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s100960050435","article-title":"Bordetella pertussis infection: pathogenesis, diagnosis, management and the role of protective immunity.","volume":"19","author":"Kerr","year":"2000","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R24-13-20210202","first-page":"23","article-title":"National consensus conference on pertussis, Toronto, Canada, May 25\u201328, 2002.","volume":"2953","year":"2003","journal-title":"Can Commun Dis Rep"},{"key":"R25-13-20210202","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/pubmed\/24.3.200","article-title":"UK guidelines for use of erythromycin chemoprophylaxis in persons exposed to pertussis.","volume":"24","author":"Dodhia","year":"2002","journal-title":"J Public Health Med"},{"key":"R26-13-20210202","doi-asserted-by":"crossref","first-page":"E42","DOI":"10.1542\/peds.104.4.e42","article-title":"Randomized, placebo-controlled trial of erythromycin estolate chemoprophylaxis for household contacts of children with culture-positive Bordetella pertussis infection.","volume":"104","author":"Halperin","year":"1999","journal-title":"Pediatrics"},{"key":"R27-13-20210202","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1086\/501863","article-title":"Azithromycin prophylaxis during a hospitalwide outbreak of a pertussis-like illness.","volume":"22","author":"Martinez","year":"2001","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R28-13-20210202","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1093\/infdis\/155.6.1210","article-title":"Use of erythromycin to prevent pertussis in newborns of mothers with pertussis.","volume":"155","author":"Granstr\u00f6m","year":"1987","journal-title":"J Infect Dis"},{"key":"R29-13-20210202","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1017\/S0950268897008571","article-title":"Review of the evidence for the use of erythromycin in the management of persons exposed to pertussis.","volume":"120","author":"Dodhia","year":"1998","journal-title":"Epidemiol Infect"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.inf.0000160916.47479.22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:41:47Z","timestamp":1785854507000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006454-200505001-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1097\/01.inf.0000160916.47479.22","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}